Comparison of the suitability of CBCT- and MR-based synthetic CTs for daily adaptive proton therapy in head and neck patients.


Journal

Physics in medicine and biology
ISSN: 1361-6560
Titre abrégé: Phys Med Biol
Pays: England
ID NLM: 0401220

Informations de publication

Date de publication:
05 12 2020
Historique:
pubmed: 13 11 2020
medline: 13 4 2021
entrez: 12 11 2020
Statut: epublish

Résumé

Cone-beam computed tomography (CBCT)- and magnetic resonance (MR)-images allow a daily observation of patient anatomy but are not directly suited for accurate proton dose calculations. This can be overcome by creating synthetic CTs (sCT) using deep convolutional neural networks. In this study, we compared sCTs based on CBCTs and MRs for head and neck (H&N) cancer patients in terms of image quality and proton dose calculation accuracy. A dataset of 27 H&N-patients, treated with proton therapy (PT), containing planning CTs (pCTs), repeat CTs, CBCTs and MRs were used to train two neural networks to convert either CBCTs or MRs into sCTs. Image quality was quantified by calculating mean absolute error (MAE), mean error (ME) and Dice similarity coefficient (DSC) for bones. The dose evaluation consisted of a systematic non-clinical analysis and a clinical recalculation of actually used proton treatment plans. Gamma analysis was performed for non-clinical and clinical treatment plans. For clinical treatment plans also dose to targets and organs at risk (OARs) and normal tissue complication probabilities (NTCP) were compared. CBCT-based sCTs resulted in higher image quality with an average MAE of 40 ± 4 HU and a DSC of 0.95, while for MR-based sCTs a MAE of 65 ± 4 HU and a DSC of 0.89 was observed. Also in clinical proton dose calculations, sCT

Identifiants

pubmed: 33179874
doi: 10.1088/1361-6560/abb1d6
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

235036

Auteurs

Adrian Thummerer (A)

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.
Both authors contributed equally to this work.
Author to whom any correspondence should be addressed.

Bas A de Jong (BA)

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.
Both authors contributed equally to this work.

Paolo Zaffino (P)

Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy.

Arturs Meijers (A)

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.

Gabriel Guterres Marmitt (GG)

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.

Joao Seco (J)

Department of Biomedical Physics in Radiation Oncology, Deutsches Krebsfoschungszentrum (DKFZ), Heidelberg, Germany.
Department of Physics and Astronomy, Heidelberg University, Heidelberg, Germany.

Roel J H M Steenbakkers (RJHM)

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.

Johannes A Langendijk (JA)

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.

Stefan Both (S)

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.

Maria F Spadea (MF)

Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy.
Both authors contributed equally to this work.

Antje C Knopf (AC)

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.
Division for Medical Radiation Physics, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany.
Both authors contributed equally to this work.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH